Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1/FOXO1 pathway

Honghong Liua Department of Endocrinology and Metabolism, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, P.R.ChinaView further author information

Jiao Wanga Department of Endocrinology and Metabolism, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, P.R.China;b Jiangxi Clinical Research Center for Endocrine and Metabolic Disease, Nanchang, P.R.China;c Jiangxi branch of national clinical research center for metabolic disease, Nanchang, P.R.ChinaView further author information

Guanru Yued Department of Medical Genetics and Cell biology, Medical College of Nanchang University, Nanchang, P.R. ChinaView further author information

Jixiong Xua Department of Endocrinology and Metabolism, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, P.R.China;b Jiangxi Clinical Research Center for Endocrine and Metabolic Disease, Nanchang, P.R.China;c Jiangxi branch of national clinical research center for metabolic disease, Nanchang, P.R.ChinaCorrespondence[email protected]
View further author information

Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1/FOXO1 pathway

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1/FOXO1 pathway

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date